Altium Wealth Management LLC Gilead Sciences, Inc. Transaction History

Altium Wealth Management LLC

$1.39 Billion
Q2 2022

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $204,920 - $256,788	-3,538 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$64.88 - $73.64 $37,241 - $42,269	574 Added 19.37%	3,538 $257,000
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $9,544 - $10,297	-141 Reduced 4.54%	2,964 $207,000
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $111,135 - $121,431	-1,751 Reduced 36.06%	3,105 $214,000
Q1 2021 May 06, 2021	SELL	$60.0 - $68.46 $176,100 - $200,930	-2,935 Reduced 37.67%	4,856 $314,000

Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $126,896 - $144,592	-2,240 Reduced 22.33%	7,791 $454,000
Q3 2020 Oct 26, 2020	SELL	$62.1 - $78.08 $124,013 - $155,925	-1,997 Reduced 16.6%	10,031 $634,000
Q2 2020 Jul 31, 2020	BUY	$72.34 - $84.0 $8,463 - $9,828	117 Added 0.98%	12,028 $925,000
Q1 2020 Apr 23, 2020	BUY	$62.63 - $80.22 $208,119 - $266,571	3,323 Added 38.69%	11,911 $890,000
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $16,021 - $17,622	-260 Reduced 2.94%	8,588 $558,000
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $53,446 - $58,995	855 Added 10.7%	8,848 $561,000
Q2 2019 Jul 18, 2019	BUY	$61.87 - $69.38 $31,801 - $35,661	514 Added 6.87%	7,993 $540,000
Q1 2019 Apr 26, 2019	BUY	$62.53 - $70.05 $36,830 - $41,259	589 Added 8.55%	7,479 $486,000
Q4 2018 Jan 18, 2019	BUY	$60.54 - $79.0 $19,978 - $26,070	330 Added 5.03%	6,890 $431,000
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $27,799 - $30,778	390 Added 6.32%	6,560 $506,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $95,698 - $111,628	1,475 Added 31.42%	6,170 $437,000
Q1 2018 Jun 06, 2018	BUY	$72.84 - $88.8 $341,983 - $416,916	4,695 New	4,695 $354,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

Black Rock Inc. New York, NY

123M
Shares

$8.16 Billion
0.21% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$7.64 Billion
0.17% of portfolio
Capital World Investors Los Angeles, CA

84.5M
Shares

$5.63 Billion
1.06% of portfolio
Capital Research Global Investors Los Angeles, CA

61.2M
Shares

$4.08 Billion
1.05% of portfolio
State Street Corp Boston, MA

57.7M
Shares

$3.84 Billion
0.19% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altium Wealth Management LLC with notifications on news.

Account